Legal & General Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-32,316
| Closed | -$100K | – | 3612 |
|
|
2021
Q4 | $100K | Hold |
32,316
| – | – | ﹤0.01% | 2909 |
|
|
2021
Q3 | $117K | Buy |
32,316
+18,384
| +132% | +$69.3K | ﹤0.01% | 2810 |
|
|
2021
Q2 | $50K | Sell |
13,932
-698
| -5% | -$2.46K | ﹤0.01% | 2952 |
|
|
2021
Q1 | $57K | Buy |
14,630
+725
| +5% | +$2.99K | ﹤0.01% | 2786 |
|
|
2020
Q4 | $59K | Hold |
13,905
| – | – | ﹤0.01% | 2758 |
|
|
2020
Q3 | $52K | Sell |
13,905
-3,711
| -21% | -$15.8K | ﹤0.01% | 2688 |
|
|
2020
Q2 | $77K | Buy |
17,616
+1,445
| +9% | +$6.49K | ﹤0.01% | 2602 |
|
|
2020
Q1 | $61K | Sell |
16,171
-3,752
| -19% | -$18.4K | ﹤0.01% | 2542 |
|
|
2019
Q4 | $126K | Buy |
19,923
+6,337
| +47% | +$37.2K | ﹤0.01% | 2525 |
|
|
2019
Q3 | $57K | Hold |
13,586
| – | – | ﹤0.01% | 2698 |
|
|
2019
Q2 | $60K | Buy |
+13,586
| New | +$63.3K | ﹤0.01% | 2703 |
|
|
2016
Q2 | – | Sell |
-6,513
| Closed | -$22K | – | 2994 |
|
|
2016
Q1 | $22K | Hold |
6,513
| – | – | ﹤0.01% | 2662 |
|
|
2015
Q4 | $31K | Hold |
6,513
| – | – | ﹤0.01% | 2635 |
|
|
2015
Q3 | $37K | Hold |
6,513
| – | – | ﹤0.01% | 2594 |
|
|
2015
Q2 | $48K | Hold |
6,513
| – | – | ﹤0.01% | 2562 |
|
|
2015
Q1 | $68K | Hold |
6,513
| – | – | ﹤0.01% | 2315 |
|
|
2014
Q4 | $79K | Hold |
6,513
| – | – | ﹤0.01% | 2152 |
|
|
2014
Q3 | $114K | Buy |
+6,513
| New | +$94.5K | ﹤0.01% | 1816 |
|
Other funds holding BDSI
Legal & General Group's BDSI Position: Q1 2022 in Review
Legal & General Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 32,316 shares — an estimated $100K sold.
Legal & General Group first reported a position in BDSI in Q3 2014 and held it in 18 quarters. The position peaked at $126K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Legal & General Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Legal & General Group sold 32,316 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $100K.
- Legal & General Group first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 18 quarters.
- Legal & General Group's BioDelivery Sciences International, Inc. position peaked at $126K in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Legal & General Group's 13F filing for Q1 2022, filed 16 May 2022.